Patents by Inventor Anders Föger

Anders Föger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery
    Publication number: 20170258711
    Abstract: The present invention relates to fatty acid acylated amino acids (FA-Daa's) acting as permeation enhancers for oral delivery of therapeutic macromolecules such as peptides and pharmaceutical compositions comprising such FA-Daa's.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 14, 2017
    Inventors: Frantisek Hubalek, Florian Anders Foeger, Abdallah Makhlof
  • Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery
    Publication number: 20150265710
    Abstract: The present invention relates to fatty acid acylated amino acids (FA-Daa's) acting as permeation enhancers for oral delivery of therapeutic macromolecules such as peptides and pharmaceutical compositions comprising such FA-Daa's.
    Type: Application
    Filed: October 16, 2013
    Publication date: September 24, 2015
    Inventors: Frantisek Hubalek, Florian Anders Foeger, Abdallah Makhlof
  • FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY
    Publication number: 20140056953
    Abstract: The present invention relates to fatty acid acylated amino acids (FA-aa's) acting as permeation enhancers for oral delivery of therapeutic macromolecules such as peptides and pharmaceutical compositions comprising such FA-aa's.
    Type: Application
    Filed: April 12, 2012
    Publication date: February 27, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Florian Anders Foeger, Abdallah Makhlof, Herbert Hoyer
  • PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF INSULIN PEPTIDES
    Publication number: 20130058999
    Abstract: The invention is related to pharmaceutical compositions suitable for oral administration of insulin peptides, methods of making such and treatment with such.
    Type: Application
    Filed: January 12, 2011
    Publication date: March 7, 2013
    Applicant: Novo Nordisk A/S
    Inventor: Florian Anders Foeger
  • STABLE NON-AQUEOUS LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING AN INSULIN
    Publication number: 20120196800
    Abstract: The invention describes a non-aqueous liquid pharmaceutical composition comprising at least one lipid and at least one insulin. Also described is a method of producing a pharmaceutical composition comprising a lipid and a method of purifying a lipid, a cosolvent, a surfactant or a pharmaceutical composition comprising a lipid.
    Type: Application
    Filed: September 16, 2010
    Publication date: August 2, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Helle Naver, Florian Anders Föger, Thomas Hoeg-Jensen, Charlotte Harkjaer Fynbo
  • PHARMACEUTICAL COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION OF DERIVATIZED INSULIN PEPTIDES
    Publication number: 20110293714
    Abstract: The invention is related to a water-free liquid or semisolid pharmaceutical composition comprising a derivatized insulin peptide, at least one polar organic solvent and at least one lipophilic component and a method of treatment using such.
    Type: Application
    Filed: September 18, 2009
    Publication date: December 1, 2011
    Applicant: NOVO NORDISK A/S
    Inventor: Florian Anders Föger
  • Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
    Publication number: 20110144010
    Abstract: The present invention relates to a solid or semi-solid pharmaceutical composition that includes a polypeptide drug, at least one polar organic solvent, at least one surfactant, at least one hydrophilic component and which composition is spontaneously dispersible.
    Type: Application
    Filed: May 30, 2008
    Publication date: June 16, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Florian Anders Föger, Per-Olof Wahlund, Tomas Landh, Simon Bjerregaard Jensen, Svend Havelund
  • Stable Non-Aqueous Pharmaceutical Compositions
    Publication number: 20100190706
    Abstract: The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia, comprising insulinotropic peptide and semi-polar protic organic solvent.
    Type: Application
    Filed: May 30, 2008
    Publication date: July 29, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: Simon Bjerregaard Jensen, Svend Havelund, Anders Föger, Bernd W. Müller
  • Stable Non-Aqueous Pharmaceutical Compositions
    Publication number: 20100144592
    Abstract: The present invention relates to shelf stable non-aqueous pharmaceutical compositions, and to the use thereof in methods of treating diabetes and hyperglycaemia, comprising dehydrated active polypeptide comprising 10-100 amino acids and at least one semi-polar protic organic solvent.
    Type: Application
    Filed: May 30, 2008
    Publication date: June 10, 2010
    Applicant: Nove Nordisk A/S
    Inventors: Simon Bjerregaard Jensen, Svend Havelund, Florian Anders Föger